Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin in Alcohol Dependency Treatment
NCT03274167Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- Jan 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence comparing Gabapentin with Placebo (2 arms). Primary endpoint: Frequency of heavy drinking at 12 weeks. Started Jan 2012; status: completed.
02
Drugs
gabapentin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT03274167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03274167.